The Lead Episode 158: A Discussion of Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

In this episode of The Lead, host Robert Schaller, DO, FHRS, is joined by Tina Baykaner, MD, MPH, and Maulin Shah, MD, to discuss the journal article, Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial. Together, they review the study's long-term follow-up findings and explore device-related complications associated with transvenous and subcutaneous defibrillator therapy.

Learning Objectives:

• Review the long-term follow-up results of the PRAETORIAN-XL Trial comparing transvenous and subcutaneous defibrillator therapy.
• Discuss device-related complications associated with transvenous and subcutaneous implantable defibrillator systems.
• Examine the clinical considerations of defibrillator therapy selection based on long-term device-related outcomes.

Host: Robert Schaller, DO, FHRS 

Guests: Tina Baykaner, MD, MPH and Maulin Shah, MD

Disclosures:

R. Schaller

• Honoraria/Speaking/Consulting Fee: Philips, Abbott Medical
• Officer/Trustee/Director/Committee Chair/Other Fiduciary Role: Imricor
• Other Financial Relationship: Other

T. Baykaner

• Honoraria/Speaking/Consulting Fee: Volta Medical, Medtronic, Pacemate, Johnson & Johnson, Abbott Medical, Boston Scientific
• Research: NIH, Boston Scientific

M Shah

• No relevant disclosures